date,title,source
Oct-23-18,Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering of Common Shares Including the Exercise of the Over-Allotment Option,GlobeNewswire
Nov-07-18,Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call,GlobeNewswire
Nov-14-18,Acasti: Fiscal 2Q Earnings Snapshot,Associated Press
Nov-14-18,Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019,GlobeNewswire
Nov-27-18,Acasti Pharma to Present at the 11th Annual LD Micro Main Event,ACCESSWIRE
Dec-28-18,Generic Industry on Path to Recovery: 3 Hot Picks for 2019,Zacks
Jan-09-19,4 Healthcare Stocks Looking To Set January Highs,ACCESSWIRE
Jan-09-19,Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office,GlobeNewswire
Feb-08-19,Acasti Pharma Schedules Third Quarter Fiscal 2019 Conference Call,GlobeNewswire
Feb-14-19,Acasti: Fiscal 3Q Earnings Snapshot,Associated Press
Feb-14-19,Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019,GlobeNewswire
Feb-21-19,Acasti Pharma Recognized in TSX Venture Exchanges 2019 Venture 50,GlobeNewswire
Mar-13-19,Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th,GlobeNewswire
Mar-26-19,Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd,GlobeNewswire
Apr-01-19,Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal,GlobeNewswire
Apr-15-19,Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia,GlobeNewswire
Apr-24-19,Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City,GlobeNewswire
May-10-19,Acasti Settles Claims with Former Chief Executive Officer,GlobeNewswire
May-15-19,"Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel",GlobeNewswire
May-21-19,Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference,GlobeNewswire
May-23-19,Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer,GlobeNewswire
Jun-04-19,Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia,GlobeNewswire
Jun-19-19,Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call,GlobeNewswire
